Vaxcyte, Inc. (PCVX)
63.37 USD-7.65%close 2026-11-13Healthcare
Gurus hold—none of the tracked superinvestors
Net buying (quarter)—latest quarter, superinvestors
Market Cap$10.03B52 Week Range: 43.06 – 73.82
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossDividend Yield: 0.00%
The live quote provider is unreachable; the last known close is shown.
Vaxcyte, Inc. (PCVX) is not among the 30 most-held stocks of the tracked superinvestor set. Price 63.37 USD; market cap $10.03B.
Price & valuation
Prev Close68.62
Open—
Day Range—
52 Week Range43.06 – 73.82
Volume—
Avg Volume (3M)—
BetaVolatility vs the market. Above 1: swings harder than the index.1.932 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossSEC 10-Q, 09/30/2026
Pro Feature
This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.
Upgrade to ProAbout
SectorHealthcare
Industry—
Employees—
Website—
Frequently Asked Questions
Which superinvestors own PCVX?
Vaxcyte, Inc. (PCVX) is not among the 30 most-held stocks of the tracked superinvestor set.
Is institutional sentiment on PCVX bullish or bearish?
PCVX is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.